Implementation of
Automated Breast Ultrasound
into Clinical Practice

Recording of a live webinar presented on December 5, 2012

A certified one-hour prerecorded webinar for radiologists.

Format: Archived Webinar
MD Credit:  1.0 AMA PRA Category 1 (Available for physician credit only)
RT Credit:   No ARRT credit available
Fee for Credit Certificate: $0

Click ENROLL NOW to register for this program

Course Overview
It has been shown that 41% of women have dense breast tissue. Recent studies report that mammographic breast density is associated with increased risk of breast cancer, making detection of cancer by traditional mammography difficult. With the passage of breast density notification legislation in several states and pending legislation in many more, breast imaging clinicians must address the need for screening options that will serve as an adjunct to traditional mammography.

With FDA approval of ABUS, the medical community is faced with evaluating ABUS in terms of providing improved care for their patients and the impact of this new technology on their medical practice. This evaluation process involves consideration of the pros and cons of the technology compared to current practice, patient selection criteria, and operational concerns.

In this activity, faculty will discuss how ABUS has impacted patient care and how ABUS technology has been integrated into their clinical practice.

Educational Objectives
At the conclusion of this activity, participants should be better able to:

• Evaluate the role of automated breast ultrasound (ABUS) when used with mammography screening patients for breast disease
• Identify the types of patients who may benefit from ABUS
• Explain the patient management and operational issues of integrating ABUS into clinical practice

Accreditation & Credit
Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and the International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Participate

• There are no fees to participate in this activity.
• To register, click ENROLL NOW, then CONTINUE, CONFIRM ORDER, and ACCESS COURSE NOW.
• Click the blue link. Complete the precourse evaluation and click SUBMIT.
• Once the precourse evaluation is submitted, click on the blue link again to view the course.
• Click on PLAYBACK. To view the streaming video, you may have to download the WebEx Player or Java.

Please note: The WebEx platform will play on desktop or laptop computers only. It will not play on mobile devices.

How to Recieve Credit

• View the entire one-hour session. The question-and-answer period at the end of the lecture is not required to receive credit.
• At the conclusion of the lecture, close the WebEx Player window. You will be redirected to the ICPME website.
• From the COURSE HOME page, click the buttons for POSTTEST and for EVALUATION.
• A passing grade of at least 75% is required to receive credit.  You may take the test up to three times.
• Upon receipt of a passing grade, click the certificate tab to print a credit certificate.

Faculty
Marc F. Inciardi, MD
Assistant Professor of Radiology
University of Kansas School of Medicine
Section Head, Breast Imaging
University of Kansas Medical Center

Dr. Inciardi is currently Assistant Professor of Radiology at University of Kansas Medical School and Section Head of Breast Imaging at University of Kansas Medical Center.

He received his medical degree from University of Oklahoma School of Medicine, followed by a residency in diagnostic radiology at University of Oklahoma Health Sciences Center and a fellowship in CT/Ultrasound at LAC-USC Medical Center.

Dr. Inciardi’s current clinical practice focuses on breast imaging, in particular mammography, MRI, and ultrasound. He has lectured extensively on breast cancer screening and serves as the principle investigator of a multicenter FDA trial to determine the utility of automated breast ultrasound in patients with dense breast tissue.

Dr. Inciardi is a member of the American College of Radiology, Radiological Society of North America, American Roentgen Ray Society, and Society of Breast Imaging.
 
Jinnah A. Phillips, MD
Section Chief of Women’s Imaging
Hartford Hospital
Director of Breast Imaging
Jefferson Radiology

Dr. Phillips currently serves as Section Chief of Women's Imaging at Hartford Hospital and Director of Breast Imaging at Jefferson Radiology in Hartford, CT.

After receiving her medical degree from the University of Utah School of Medicine, Dr. Phillips went on to complete an internship in internal medicine at University of Pittsburg Medical Center, followed by a residency in diagnostic radiology at UPMC.  She completed a fellowship in women’s imaging at UPMC before joining Jefferson Radiology as a women’s imaging specialist.

Dr. Phillips has an active role at the American College of Radiology, serving as Editor and Section Chair for the ACR Breast Imaging e-Learning Subcommittee.  In addition to the ACR, Dr. Phillips is a member of the Society of Breast Imaging, American Roentgen Ray Society, and Radiological Society of North America
 
Disclosure Information
The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty has reported the following financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Marc F. Inciardi, MD has received consulting fees, fees for non-CME/CE services, and contracted research with U-Systems.
Jinnah A. Phillips, MD has no financial relationships to disclose.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Sharon Cancino                            
Laura Excell, ND, NP, MS, MA, LPC, NCC        
Trace Hutchison, PharmD    
Samantha Mattiucci, PharmD                
Linda McLean, MS
Victoria Phoenix, BS
Patricia Staples, MSN, NP-C, CCRN
 

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ICPME and U-Systems, Inc. do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the view of PIM, ICPME and U-Systems, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 x10


JOINTLY SPONSORED BY

               


SUPPORTED BY AN EDUCATIONAL GRANT FROM

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.